1. Clarke, M., & Oxman, A. (2003). Cochrane Reviewers’ Handbook 4.2.0. http://www.cochrane.dk/cochrane/handbook/handbook.html .
2. Higgins, J. P. T., & Green, S. (Eds.). (2005). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. In The Cochrane Library. Chichester: John Wiley & Sons, Ltd.
3. Mayhew, A. (2002). EPOC: The data collection checklist. Ontario: The Cochrane Effective Practice and Organisations of Care Review Group.
4. Garces, A. H., Mora, P. A., Alves, F. V., do Carmo, C. C., Grazziotin, R., Fernandes, A. C., et al. (2013). First-line paclitaxel and carboplatin in persistent/recurrent or advanced cervical cancer: A retrospective analysis of patients treated at Brazilian National Cancer Institute. International Journal of Gynecological Cancer, 23, 743–748.
5. Herrera, F. G., & Prior, J. O. (2013). The role of PET/CT in cervical cancer. Frontier in Oncology, 3, 34.